# Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment

> **NCT03525652** · PHASE1,PHASE2 · UNKNOWN · sponsor: **The First Affiliated Hospital of Guangdong Pharmaceutical University** · enrollment: 30 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** Therapeutic vaccine
- **BIOLOGICAL:** PD-1 Knockout T Cells

## Key facts

- **NCT ID:** NCT03525652
- **Lead sponsor:** The First Affiliated Hospital of Guangdong Pharmaceutical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-22
- **Primary completion:** 2021-02-22
- **Final completion:** 2021-08-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03525652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03525652, "Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03525652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*